Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-21

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this research grant are to determine the association of hypoxia with the severity of osteoporosis in the patients with bronchiectasis and whether the mechanism of inflammation is triggered by inflammasones, which makes it more prone to osteoporosis in patients with bronchiectasis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Breathing and Bones Initiative

NCT01161680

Osteoporosis Obstructive Lung Disease

COMPLETED

CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD

NCT03534934

Pulmonary Disease, Chronic Obstructive Osteoporosis

COMPLETED NA

Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids

NCT01246375

Osteoporosis

UNKNOWN NA

Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD)

NCT01549028

COPD, Osteoporosis

UNKNOWN NA

Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis

NCT01067248

Pulmonary Disease, Chronic Obstructive Osteoporosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

80 patients with proven bronchiectasis, diagnosed by high-resolution computed tomography (HRCT), will be recruited from our outpatient clinic of Chang Gung Memorial Hospital with written informed consent. Inclusion criteria are: daily sputum \> 10 ml; absence of asthma or other unstable systemic diseases; and "steady-state" bronchiectasis (\< 10% alteration of 24 h sputum volume, FEV1, and FVC, and in the absence of deterioration in respiratory symptoms at baseline visits). Exclusion criteria include: unreliable clinic attendance; regular user of inhaled or oral corticosteroids; history of lung resection and known asthma defined according to American Thoracic Society guidelines.

The lung function and desaturation will be assessed by six-minute walking tests and the severity of disease will be evaluated by HRCT scores. Peripheral blood sample (40ml/person) is performed to analyze the bone turnover markers and the level of Hif in PBMC.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiectasis Adult Osteoporosis, Osteopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

desaturation

ΔSpO2 \>10% or lowest SpO2\<90 during baseline six minute walk test

Check serum level of inflammasone, such as IL-1beta, TGF-beta TRT-PCR for PBMC

Inflammasone

Intervention Type OTHER

Serum level of cytokine and RT-PCR for PBMC

non-desaturation

ΔSpO2 \<10% and lowest SpO2\>90 during baseline six minute walk test

Check serum level of inflammasone, such as IL-1beta, TGF-beta TRT-PCR for PBMC

Inflammasone

Intervention Type OTHER

Serum level of cytokine and RT-PCR for PBMC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inflammasone

Serum level of cytokine and RT-PCR for PBMC

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. willing to sign a written consent form
2. Male and female subjects with bronchiectasis diagnosed by high-resolution computed tomography
3. willing to accept 6-minute exercise pulmonary function test and blood draw
4. Men and women over the age of 20
5. Has undergone chest computed tomography and bone density examination in the recent five years

Exclusion Criteria

1. pregnant women or lactating women
2. asthma, lung resection history before the screening period
3. active Tuberculosis infection
4. Have received oral steroid treatment within 30 days
5. current acute attack or clinical symptoms instability of bronchiectasis

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No